DNDi hosted a session entitled “Post-Kala-Azar Dermal Leishmaniasis (PKDL): A Neglected Entity in Visceral Leishmaniasis: Introduction of a PKDL Consortium”, and also presented oral presentations and several posters.
See a Summary of DNDi‘s activities !
| [Tuesday, Nov 13, 2012, 10:15 AM -12:00 PM] Post-Kala-Azar Dermal Leishmaniasis (PKDL): A Neglected Entity in Visceral Leishmaniasis: Introduction of a PKDL Consortium |
DNDi hosted a session entitled “Post-Kala-Azar Dermal Leishmaniasis (PKDL): A Neglected Entity in Visceral Leishmaniasis: Introduction of a PKDL Consortium”, and also presented oral presentations and several posters.
P. falciparum parasite clearance in patients treated with artesunate-amodiaquine (ASAQ) vs. comparator groups, sub-Saharan Africa by Julien Zwang, Grant Dorsey, Abdoulaye Djimdé, Corine Karema, Andreas Mårtensson, Jean-Louis Ndiaye, JP Guthmann, Sodiomon Sirima, Phillipe Brasseur, Umberto d’Alessandro, Piero L. Olliaro
Clinical tolerability of artesunate-amodiaquine vs. comparator treatments for uncomplicated falciparum malaria in Sub-Saharian Africa, an individual patient data analysis by Zang, Dorsey, Djimdé, Karema, Martensson, Ndiaye, Sirima, Olliaro
Changes in malaria prevalence and health provider’s behaviour toward fever with the introduction of ACT and RDT at peripheral health centre level in South-western Senegal (2000-2011) by P. Brasseur, M. Badiane, M. Cisse, M. Vaillant, P. Olliaro
